Ckj consolidation among Q1 Urology and Nephrology journals

Abstract

The Clinical Kidney Journal (ckj) impact factor from Clarivate’s Web of Science for 2019 was 3.388. This consolidates ckj among journals in the top 25% (first quartile, Q1) in the Urology and Nephrology field according to the journal impact factor. The manuscripts contributing the most to the impact factor focused on chronic kidney disease (CKD) epidemiology and evaluation, CKD complications and their management, cost-efficiency of renal replacement therapy, pathogenesis of CKD, familial kidney disease and the environment–genetics interface, onconephrology, technology, SGLT2 inhibitors and outcome prediction. We provide here an overview of the hottest and most impactful topics for 2017–19.

Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021

“…In 2012, NDT Plus evolved into the Clinical Kidney Journal ( CKJ ), under the leadership of Alain Meyrier. From 2014 onward, Alberto Ortiz has been the Editor-in-Chief (EiC), a term that will end in May 2022 when Maria José Soler will become the first female CKJ EiC [ 1 , 2 ]. As the last full year as EiC ends, it is worth reflecting on the path so far and on the most impactful topics published in CKJ .…”